Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd.’s Net Profit Dropped 0.7% in First Quarter of 2023

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. (湖南达嘉维康医药产业股份有限公司) (301126.SZ) reported a net profit of 18.9 million yuan in the first quarter of 2023, down 0.7% year-on-year.

Meanwhile, the company posted 876.7 million yuan in revenue, up 39.7% year-on-year.

At the end of the reporting period, it had 4.2 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 56.1%.